Related references
Note: Only part of the references are listed.High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
Sahajal Dhooria et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Follow-up CT of reversed halo sign in SARS-CoV-2 delta VOC pneumonia: A report of two cases
Jing Wu et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature
Himanshu Pruthi et al.
MYCOPATHOLOGIA (2022)
Serum iron indices in COVID-19-associated mucormycosis: A case-control study
Mohan H. Kumar et al.
MYCOSES (2022)
Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals
Danila Seidel et al.
MYCOSES (2022)
COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico
Salvador Guzman-Castro et al.
MYCOSES (2022)
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
Jean-Pierre Gangneux et al.
LANCET RESPIRATORY MEDICINE (2022)
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl et al.
LANCET MICROBE (2022)
CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review
Mandeep Garg et al.
RADIOLOGY (2022)
The Reversed Halo Sign and la COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging Finding
Anderson Ribeiro de Sales et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2021)
Safety and Efficacy of Bronchoscopy in Critically Ill Patients With Coronavirus Disease 2019
Stephanie H. Chang et al.
CHEST (2021)
Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit
Bindu Mulakavalupil et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt
Mostafa Alfishawy et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Andre K. Johnson et al.
MEDICAL MYCOLOGY CASE REPORTS (2021)
Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study
Philipp Koehler et al.
MYCOSES (2021)
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis
Valliappan Muthu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Molecular identification of pathogenic fungi in formalin- fixed and paraffin-embedded tissues
Joseph Jillwin et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2021)
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2021)
Is high-dose glucocorticoid beneficial in COVID-19?
Valliappan Muthu et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series
Eelco F. J. Meijer et al.
MYCOSES (2021)
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
Christoph Zurl et al.
JOURNAL OF FUNGI (2021)
Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
Salman Hussain et al.
JOURNAL OF FUNGI (2021)
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Abanoub Riad et al.
JOURNAL OF FUNGI (2021)
Role of flexible bronchoscopy in the diagnosis of invasive fungal infections
Valliappan Muthu et al.
MYCOSES (2021)
In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles
Andrew M. Borman et al.
JOURNAL OF FUNGI (2021)
Aspergillus terreus Species Complex
Cornelia Lass-Florl et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
Paul E. Verweij et al.
INTENSIVE CARE MEDICINE (2021)
Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID-19): A multicentre experience
Nilgun Yilmaz Demirci et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations
Nurettin Bayram et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2021)
Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States
Hamid Badali et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu et al.
MYCOPATHOLOGIA (2021)
Mucormycosis and COVID-19: An epidemic within a pandemic in India
Lav Selarka et al.
MYCOSES (2021)
Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study
Valliappan Muthu et al.
MYCOSES (2021)
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries
Shivaprakash M. Rudramurthy et al.
MYCOSES (2021)
COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients
A. Ramaswami et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)
Cavity in pulmonary mucormycosis: Is it rare?
Valliappan Muthu et al.
TROPICAL DOCTOR (2021)
Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis
Mohan Venkatesh Pulle et al.
LUNG INDIA (2021)
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India
Atul Patel et al.
EMERGING INFECTIOUS DISEASES (2021)
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
Salman Hussain et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
COVID-19-Associated Mold Infection in Critically Ill Patients, Chile
Ricardo Rabagliati et al.
EMERGING INFECTIOUS DISEASES (2021)
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
Deepak Garg et al.
MYCOPATHOLOGIA (2021)
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
A. Patel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Bronchoscopy in Patients with COVID-19 with Invasive Mechanical Ventilation: A Single-Center Experience
Alfons Torrego et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Pharmacokinetics and Pharmacodynamics of Posaconazole
Lu Chen et al.
DRUGS (2020)
Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
Helene Guegan et al.
JOURNAL OF INFECTION (2020)
Transforming a General Hospital to an Infectious Disease Hospital for COVID-19 Over 2 Weeks
Navin Pandey et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
Christoph Zurl et al.
JOURNAL OF FUNGI (2020)
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Philipp Koehler et al.
LANCET INFECTIOUS DISEASES (2020)
Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
Xun-Jie Cao et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Posaconazole salvage therapy: The Posifi study
Jestis Fortun et al.
MYCOSES (2019)
Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis
Hayoung Choi et al.
JOURNAL OF THORACIC DISEASE (2019)
Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival
Ashrit Multani et al.
MYCOSES (2019)
Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis
Chun-Yu Lin et al.
MICROORGANISMS (2019)
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2019)
Clinical features of pulmonary mucormycosis in patients with different immune status
Min Peng et al.
JOURNAL OF THORACIC DISEASE (2019)
Global Epidemiology of Mucormycosis
Hariprasath Prakash et al.
JOURNAL OF FUNGI (2019)
Molecular Strategies to Diagnose Mucormycosis
Laurence Millon et al.
JOURNAL OF FUNGI (2019)
CT-guided Core-Needle Biopsy of the Lung Is Safe and More Effective than Fine-Needle Aspiration Biopsy in Patients with Hematologic Malignancies
Gaurav Watane et al.
RADIOLOGY-CARDIOTHORACIC IMAGING (2019)
Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings
Bo Da Nam et al.
EUROPEAN RADIOLOGY (2018)
Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time
Mark M. Hammer et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Surgical Treatment of Multifocal Pulmonary Mucormycosis
Sara E. A. Mills et al.
ANNALS OF THORACIC SURGERY (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole
Matthew W. McCarthy et al.
CLINICAL PHARMACOKINETICS (2018)
Challenges in the diagnosis and treatment of mucormycosis
A. Skiada et al.
MEDICAL MYCOLOGY (2018)
Retrospective study of 25 cases of pulmonary mucormycosis in acute leukaemia
D. Caillot et al.
REVUE DES MALADIES RESPIRATOIRES (2018)
Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL
Elisabeth Wehrle-Wieland et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience
Cornelia Lass-Floerl et al.
INFECTION (2017)
Antifungal resistance in mucorales
E. Dannaoui
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis
Wei Zhou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Chronic pulmonary mucormycosis: an emerging fungal infection in diabetes mellitus
Nousheen Iqbal et al.
JOURNAL OF THORACIC DISEASE (2017)
Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients
C. Henzler et al.
SCIENTIFIC REPORTS (2017)
CT-Guided Percutaneous Lung Biopsies in Patients With Suspicion for Infection May Yield Clinically Useful Information
Brian M. Haas et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
Oliver A. Cornely et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis
Xin-yu Shi et al.
RESPIRATORY MEDICINE (2016)
Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience
Pankaj Saxena et al.
ANZ JOURNAL OF SURGERY (2015)
Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis
J. Jung et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
F. Lanternier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients
O. Yazicioglu Mocin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia
Sanjeev Kumar Sharma et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2013)
Risk Factors for Mortality in Patients with Invasive Mucormycosis
Hyo-Lim Hong et al.
INFECTION AND CHEMOTHERAPY (2013)
In Vitro and In Vivo Activities of Posaconazole and Amphotericin B in a Murine Invasive Infection by Mucor circinelloides: Poor Efficacy of Posaconazole
Valentina Salas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales
Roxana G. Vitale et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Zygomycosis: conventional laboratory diagnosis
C. Lass-Floerl
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria
Brahm H. Segal et al.
CLINICAL INFECTIOUS DISEASES (2008)
Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2006)
Utility of computed tomography (CT) and of fine needle aspiration biopsy (FNAB) in early diagnosis of fungal pulmonary infections.: Study of infections from filamentous fungi in haematologically immunodeficient patients
G Carrafiello et al.
RADIOLOGIA MEDICA (2006)
Pulmonary mucormycosis: Two of a kind
Ritesh Agarwal et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2005)
Intradialytic administration of amphotericin B: Clinical observations on efficacy and safety
JE Wood et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2004)
Cunninghamella bertholletiae infection in a bone marrow transplant patient:: Amphotericin lung penetration, MIC determinations, and review of the literature
KW Garey et al.
PHARMACOTHERAPY (2001)